PODD Insulet Corp.
$136.13
Insulet Corp. (PODD) is expected to report earnings on November 5, 2026, before the market open. The consensus earnings estimate is $1.59 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +6.4% since its last earnings release on August 5, 2026.
Insulet Beat Consensus Estimates, Reaffirms
Wednesday, August 5, 2026 · 7:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 5
Thursday · 7:00 AM ET
Earnings Whisper
-
vs $1.59
Rev est $833.8M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$141.89
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Insulet Corp.
Insulet Corp is a medical device company that develops, manufactures and markets OmniPod Insulin Management System, an insulin infusion system for people with insulin-dependent diabetes.
Sector
Healthcare
Industry
Medical Appliances/Equipment
Held By 12 ETFs, by dollar flow
- IYH iShares U.S. Healthcare ETF
- IYH iShares U.S. Healthcare ETF
- XLV Health Care Select Sector SPDR Fund
- XLV Health Care Select Sector SPDR Fund
- IXJ iShares Global Healthcare ETF
- IXJ iShares Global Healthcare ETF
- QQQJ Invesco NASDAQ Next Gen 100 ETF
- QQQJ Invesco NASDAQ Next Gen 100 ETF
- BMED iShares Health Innovation Active ETF
- BMED iShares Health Innovation Active ETF
- IHI iShares U.S. Medical Devices ETF
- IHI iShares U.S. Medical Devices ETF
Charts powered in part by Lightweight Charts™ by TradingView.